Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-057136
Filing Date
2014-08-06
Accepted
2014-08-06 06:05:06
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-14097_110q.htm 10-Q 784751
2 EX-31.1 a14-14097_1ex31d1.htm EX-31.1 11603
3 EX-31.2 a14-14097_1ex31d2.htm EX-31.2 12112
4 EX-32.1 a14-14097_1ex32d1.htm EX-32.1 8128
11 GRAPHIC g140971fn03i001.jpg GRAPHIC 16590
12 GRAPHIC g140971fn03i002.jpg GRAPHIC 12773
13 GRAPHIC g140971fn05i001.jpg GRAPHIC 7054
  Complete submission text file 0001104659-14-057136.txt   4814992

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snta-20140630.xml EX-101.INS 612581
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20140630.xsd EX-101.SCH 32367
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20140630_cal.xml EX-101.CAL 43701
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20140630_lab.xml EX-101.LAB 563096
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20140630_pre.xml EX-101.PRE 281337
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20140630_def.xml EX-101.DEF 154173
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 141018002
SIC: 2834 Pharmaceutical Preparations